These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12702519)

  • 1. The role of taxanes as a component of neoadjuvant chemotherapy for breast cancer.
    Gogas H; Fountzilas G
    Ann Oncol; 2003 May; 14(5):667-74. PubMed ID: 12702519
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
    Sparano JA
    Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of taxanes in the treatment of breast cancer.
    Capri G; Tarenzi E; Fulfaro F; Gianni L
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):68-75. PubMed ID: 8614849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of recent trials of chemotherapy for advanced breast cancer: the taxanes.
    Clemons M; Leahy M; Valle J; Jayson G; Ranson M; Howell A
    Eur J Cancer; 1997 Nov; 33(13):2183-93. PubMed ID: 9470804
    [No Abstract]   [Full Text] [Related]  

  • 6. Paclitaxel in doxorubicin-resistant metastatic breast cancer patients.
    Anand A; Anand A
    J Natl Cancer Inst; 1995 Nov; 87(21):1642. PubMed ID: 7563210
    [No Abstract]   [Full Text] [Related]  

  • 7. Integration of docetaxel into adjuvant breast cancer treatment regimens.
    Hortobagyi GN
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):27-33. PubMed ID: 12108895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-induced remission in docetaxel-refractory anthracycline-pretreated metastatic breast cancer.
    Suzuma T; Sakurai T; Yoshimura G; Umemura T; Tamaki T; Naito Y
    Anticancer Drugs; 2000 Aug; 11(7):569-71. PubMed ID: 11036960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxanes in the treatment of early breast cancer.
    Ring AE; Ellis PA
    Cancer Treat Rev; 2005 Dec; 31(8):618-27. PubMed ID: 16266787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current developments in use of docetaxel (taxotere) in gynecologic oncology].
    Jackisch C
    Med Klin (Munich); 1998 Sep; 93 Suppl 3():4-15. PubMed ID: 9796219
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.
    Costa SD; von Minckwitz G; Raab G; Blohmer JU; Dresel V; Eidtmann H; Hilfrich J; Jackisch C; Merkle E; Gademann G; Kaufmann M
    Semin Oncol; 1999 Jun; 26(3 Suppl 9):24-31. PubMed ID: 10426456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxanes in the treatment of breast cancer: a prodigy comes of age.
    Miller KD; Sledge GW
    Cancer Invest; 1999; 17(2):121-36. PubMed ID: 10071597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Docetaxel (taxotere) for therapy of breast carcinoma. Highest effectiveness with moderate side effects].
    von Minckwitz G; Costa SD
    Med Klin (Munich); 1997 Sep; 92 Suppl 4():4-9. PubMed ID: 9446016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The taxoids: paclitaxel and docetaxel.
    Gelmon K
    Lancet; 1994 Nov; 344(8932):1267-72. PubMed ID: 7967989
    [No Abstract]   [Full Text] [Related]  

  • 15. Preclinical evaluation of new taxoids.
    Bissery MC
    Curr Pharm Des; 2001 Sep; 7(13):1251-7. PubMed ID: 11472265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of taxanes in the management of breast cancer.
    Nabholtz JM
    Semin Oncol; 1999 Jun; 26(3 Suppl 8):1-3. PubMed ID: 10403466
    [No Abstract]   [Full Text] [Related]  

  • 17. [Docetaxel was effective as neoadjuvant chemotherapy for patients after failure of trans-arterial neoadjuvant chemotherapy with CEF in 2 cases of advanced breast cancer].
    Ogawa T; Nagata S; Suzuki H; Onzuka T; Yamanaka N; Kawano R; Yoshida J; Shinohara M; Sumitomo K; Matsuo K; Kuroki S
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1743-5. PubMed ID: 11708023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxoid compounds in breast cancer: current status and future prospects.
    Piccart MJ
    Cancer Treat Res; 1995; 78():185-207. PubMed ID: 8595143
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intra-arterial infusion chemotherapy with docetaxel for locally advanced breast cancer and inflammatory breast cancer].
    Doi K; Ohchi T; Kudo S; Takahashi M; Sakamoto T; Ochiai T; Sakae T; Ishihara A
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1823-5. PubMed ID: 11086421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ongoing US cooperative group trials using taxanes in the adjuvant setting.
    Davidson NE
    Clin Breast Cancer; 2002 Oct; 3 Suppl 2():S53-8. PubMed ID: 12435293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.